SCHEMBL95762

SCHEMBL95762

O=S(=O)(O)c1cc2c(S(=O)(=O)O)ccc3c(S(=O)(=O)O)cc4c(O)ccc1c4c32

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNNI3 P19429 1/20 0.49
▸ TNNT2 P45379 1/20 0.49
▸ TNNC1 P63316 1/20 0.49
▸ HKDC1 Q2TB90 1/20 0.49
▸ AURKA O14965 1/20 0.47
▸ AURKB Q96GD4 1/20 0.47
▸ COMT P21964 1/20 0.44
▸ LDHA P00338 1/20 0.39
▸ MPL P40238 7/20 0.38
▸ CTRC Q99895 1/20 0.38
▸ NT5E P21589 1/20 0.38
▸ CYP1A2 P05177 2/20 0.37
▸ HSD17B10 Q99714 3/20 0.37
▸ HPGD P15428 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ ATIC P31939 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11527283 0.98 TNNI3 (0.48) TNNI3TNNT2TNNC1HKDC1AURKA
SCHEMBL30081118 0.89 AURKA (0.47) TNNI3TNNT2TNNC1HKDC1AURKA
SCHEMBL21113847 0.89 TNNI3 (0.42) TNNI3TNNT2TNNC1HKDC1AURKA
SCHEMBL11231720 0.89 AURKA (0.47) TNNI3TNNT2TNNC1HKDC1AURKA
SCHEMBL461763 0.89 TNNI3 (0.42) TNNI3TNNT2TNNC1HKDC1AURKA
SCHEMBL461765 0.89 TNNI3 (0.42) TNNI3TNNT2TNNC1HKDC1AURKA
SCHEMBL1979115 0.84 AURKB (0.44) TNNI3TNNT2TNNC1HKDC1AURKA
SCHEMBL14742104 0.83 AURKA (0.46) TNNI3TNNT2TNNC1HKDC1AURKA
SCHEMBL11528724 0.81 AURKA (0.40) TNNI3TNNT2TNNC1HKDC1AURKA
SCHEMBL11524521 0.80 AURKA (0.54) TNNI3TNNT2TNNC1HKDC1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 537 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017027062-A1 PROBES FOR RAPID AND SPECIFIC DETECTION OF MYCOBACTERIA THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2017-02-16 — — WO claimed
US-20170044593-A1 PROBES FOR RAPID AND SPECIFIC DETECTION OF MYCOBACTERIA THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2017-02-16 — — US claimed
US-20140024137-A1 METHODS AND COMPOSITIONS RELATED TO NUCLEIC ACID BINDING ASSAYS NUBAD LLC 2014-01-23 — — US claimed
US-20130344588-A1 DEVICES AND METHODS FOR CONCENTRATION AND ANALYSIS OF FLUIDS MEDICAL UNIVERSITY OF SOUTH CAROLINA (US) 2013-12-26 — — US claimed
EP-2330908-A1 FLUORESCENT CDK INHIBITORS FOR TREATMENT OF CANCER Georgetown University (US) 2011-06-15 — — EP claimed
WO-2010019967-A1 FLUORESCENT CDK INHIBITORS FOR TREATMENT OF CANCER GEORGETOWN UNIVERSITY (US) 2010-02-18 — — WO claimed
EP-0087060-A2 Fluorescent make-up A.W. Faber - Castell GmbH & Co. (DE) 1983-08-31 — — EP claimed
US-4136229-A SECURITY PAPER SOCIETE ANONYME DITE: ARJOMARI-PRIOUX (FR) 1979-01-23 — — US claimed
JP-2202561-A — — None — — JP disclosed
US-20250361270-A1 TARGETED DELIVERY SYSTEM AND METHODS OF USE THEREFOR SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST (US) 2025-11-27 — — US disclosed
US-12195558-B2 Targeted delivery system and methods of use therefor Sanford Burnham Prebys Medical Discovery Institute (US) 2025-01-14 — — US disclosed
US-20240150397-A1 TARGETED DELIVERY SYSTEM AND METHODS OF USE THEREFOR Sanford Burnham Prebys Medical Discovery Institute 2024-05-09 — — US disclosed
US-20230381329-A1 Zwitterion Polymer-Drug Conjugates UNIV UTAH RES FOUND (US) 2023-11-30 — — US disclosed
US-20230384299-A1 FLUORESCENT MICROSPHERES EVENLY COATED WITH MAGNETIC PARTICLES AND METHODS OF USE EMISSION INC. (US) 2023-11-30 — — US disclosed
WO-1995030919-A1 ILLUMINATOR ELEMENTS FOR CONVENTIONAL LIGHT MICROSCOPES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1995-11-16 — — WO disclosed
JP-H02202561-A WATER-BASED CORRECTING LIQUID PENTEL KK 1990-08-10 — — JP disclosed
EP-0087060-B1 FLUORESCENT MAKE-UP A.W. Faber - Castell GmbH & Co. (DE) 1986-07-16 — — EP disclosed
EP-0087060-A2 Fluorescent make-up A.W. Faber - Castell GmbH & Co. (DE) 1983-08-31 — — EP disclosed
EP-0087060-A2 Fluorescent make-up A.W. Faber - Castell GmbH & Co. (DE) 1983-08-31 — — EP disclosed
US-4136229-A SECURITY PAPER SOCIETE ANONYME DITE: ARJOMARI-PRIOUX (FR) 1979-01-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170044593-A1 PROBES FOR RAPID AND SPECIFIC DETECTION OF MYCOBACTERIA DPEP1, MRPL21, RCE1 TNNI3 2325/4885TNNT2 2670/4885TNNC1 1139/4885
US-20230381329-A1 Zwitterion Polymer-Drug Conjugates ZW10, NUP205, DNPEP TNNI3 817/4885TNNT2 1494/4885TNNC1 1631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback